Epsolay
Payments companies reported to CMS as associated with Epsolay. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Epsolay, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Epsolay
These are the largest totals companies reported as associated with Epsolay. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Julie Harper | Birmingham, AL | Dermatology | $69,919.57 |
| Hilary Baldwin | Brooklyn, NY | Dermatology | $68,478.40 |
| Linda Stein Gold | West Bloomfield, MI | Dermatology | $49,741.73 |
| Edward Lain | Austin, TX | Dermatology | $42,961.53 |
| Omar Noor | Somerset, NJ | $41,953.28 | |
| Joshua Grosshandler | Westerville, OH | Dermatology | $36,584.78 |
| Daniel Carrasco | Austin, TX | Dermatology | $36,119.79 |
| Duane Dilworth | Saint Louis, MO | Dermatology | $34,021.88 |
| Oanh Lauring | Nottingham, MD | Dermatology | $33,537.19 |
| Nicole Lee | Garden City, NY | Dermatology | $33,253.03 |
Prescribed Epsolay?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.